Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Their use in clinical practice is considered off-label, based on emerging research, clinical experience, and patient-specific therapeutic goals
Over a period of time, KD has been evaluated in 2 uncontrolled and 1 placebo-controlled clinical trial, while AMD has been evaluated in 1 clinically controlled open-labeled clinical trial for its efficacy against ASD [165]
doi:10.1042/bj0530353
S., & Al Talebi, Z
Copper treatment led to similar global downregulation in both cell types, though 409 genes were upregulated in ATP7B-KO cells compared to HepG2 cells
per-compound and per-lot detail accompanies each quote
US$ 25.45
US$ 28.77
US$ 27.73
US$ 23.68
